Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 11, 2015
Patent Application Number
12958278
Date Filed
December 1, 2010
Patent Citations Received
Patent Primary Examiner
Patent abstract
This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
